Ganglioneuroma staging: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
|||
| Line 6: | Line 6: | ||
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name="pmid19047290">{{cite journal| author=Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al.| title=The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. | journal=J Clin Oncol | year= 2009 | volume= 27 | issue= 2 | pages= 298-303 | pmid=19047290 | doi=10.1200/JCO.2008.16.6876 | pmc=PMC2650389 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19047290 }} </ref> | According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name="pmid19047290">{{cite journal| author=Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al.| title=The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. | journal=J Clin Oncol | year= 2009 | volume= 27 | issue= 2 | pages= 298-303 | pmid=19047290 | doi=10.1200/JCO.2008.16.6876 | pmc=PMC2650389 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19047290 }} </ref> | ||
==Staging== | ==Staging== | ||
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name=staging>{{cite journal |last=Adam |first=O |last2=Boia |first2=ES |date=2007 |title=ganglioneuroma |url=http://www.jurnalulpediatrului.ro/pages/arhiva/39-40/39-40-IV-11.pdf |journal=jurnalul pediatrului |publisher= |volume=10 |issue=39-40|doi= |access-date=10 September 2015}}</ref> | |||
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on [[clinical]], radiologic, and [[surgical]] features.<ref name= | |||
'''Stage 1''' | '''Stage 1''' | ||
Revision as of 14:47, 10 September 2015
|
Ganglioneuroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ganglioneuroma staging On the Web |
|
American Roentgen Ray Society Images of Ganglioneuroma staging |
|
Risk calculators and risk factors for Ganglioneuroma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]
Staging
According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[2]
Stage 1
- Localized tumor confined to the area of origin
- Complete gross excision, with or without microscopically residual disease
- Identifiable ipsilateral and contralateral lymph node negative microscopically
Stage 2A
- Unilateral tumor with incomplete gross excision
- Identifiable ipsilateral nonadherent lymph node negative microscopically
Stage 2B
- Unilateral tumor with complete or incomplete gross excision
- Positive ipsilateral nonadherent lymph nodes
- Identifiable contralateral lymph node negtive microscopically
Stage 3
- Tumor infiltrating across the midline (vertebral column) with or without regional lymph node involvement
- or
- Unilateral tumor with contraateral regional lymph node involvement
- or
- Midline tumor with bilateral regional lymph node involvement or extension by infiltration
Stage 4
- Dissemination of tumor to distant lymph nodes, bone, bone marrow, liver or other organs (except as defined in stage 4S)
stage 4S
- Localized primary tumor as defined for stage 1 or 2 with dissemination limited to liver, skin, and/or bone marrow (<10% tumor) in infants younger than 1 yr
References
- ↑ Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K; et al. (2009). "The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report". J Clin Oncol. 27 (2): 298–303. doi:10.1200/JCO.2008.16.6876. PMC 2650389. PMID 19047290.
- ↑ Adam, O; Boia, ES (2007). "ganglioneuroma" (PDF). jurnalul pediatrului. 10 (39–40). Retrieved 10 September 2015.